183 related articles for article (PubMed ID: 32421185)
1. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
2. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.
Keating NL; Jhatakia S; Brooks GA; Tripp AS; Cintina I; Landrum MB; Zheng Q; Christian TJ; Glass R; Hsu VD; Kummet CM; Woodman S; Simon C; Hassol A;
JAMA; 2021 Nov; 326(18):1829-1839. PubMed ID: 34751709
[TBL] [Abstract][Full Text] [Related]
3. Practice patterns among oncologists participating in the oncology care model after three years.
Walker B; Wilfong L; Frytak J; Robert N
J Cancer Policy; 2021 Sep; 29():100294. PubMed ID: 35559949
[TBL] [Abstract][Full Text] [Related]
4. Association of Oncologist Participation in Medicare's Oncology Care Model With Patient Receipt of Novel Cancer Therapies.
Manz CR; Tramontano AC; Uno H; Parikh RB; Bekelman JE; Schrag D
JAMA Netw Open; 2022 Sep; 5(9):e2234161. PubMed ID: 36173630
[TBL] [Abstract][Full Text] [Related]
5. Association Between a National Insurer's Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending.
Bekelman JE; Gupta A; Fishman E; Debono D; Fisch MJ; Liu Y; Sylwestrzak G; Barron J; Navathe AS
J Clin Oncol; 2020 Dec; 38(34):4055-4063. PubMed ID: 33021865
[TBL] [Abstract][Full Text] [Related]
6. Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients.
Dean EB; Johnson P; Bond AM
JAMA Netw Open; 2021 Jan; 4(1):e2034776. PubMed ID: 33502485
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Physicians Participating in Medicare's Oncology Care Model Bundled Payment Program.
Parikh RB; Bekelman JE; Huang Q; Martinez JR; Emanuel EJ; Navathe AS
J Oncol Pract; 2019 Oct; 15(10):e897-e905. PubMed ID: 31393806
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Differences in Clinical Activity and Medicare Payments Among Female and Male Radiation Oncologists.
Valle L; Weng J; Jagsi R; Chu FI; Ahmad S; Steinberg M; Raldow A
JAMA Netw Open; 2019 Mar; 2(3):e190932. PubMed ID: 30901047
[TBL] [Abstract][Full Text] [Related]
9. Association of Multiple Hospital Affiliations With Clinician Service Use, Breadth of Procedures, and Costs.
Linde S; Beilfuss S
JAMA Netw Open; 2021 Dec; 4(12):e2139169. PubMed ID: 34913978
[TBL] [Abstract][Full Text] [Related]
10. Health care utilization and costs by site of service for nonmetastatic breast cancer patients treated with trastuzumab.
Parthan A; Santos E; Becker L; Small A; Lalla D; Brammer M; Teitelbaum A
J Manag Care Spec Pharm; 2014 May; 20(5):485-93. PubMed ID: 24761820
[TBL] [Abstract][Full Text] [Related]
11. Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab.
Keating NL; O'Malley AJ; Onnela JP; Gray SW; Landon BE
JAMA Netw Open; 2020 Jan; 3(1):e1918586. PubMed ID: 31899533
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of trends in the cost of initial cancer treatment.
Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
[TBL] [Abstract][Full Text] [Related]
13. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
[TBL] [Abstract][Full Text] [Related]
14. Association Between a Bundled Payment Program for Lower Extremity Joint Replacement and Patient Outcomes Among Medicare Advantage Beneficiaries.
Sutherland A; Boudreau E; Bowe A; Huang Q; Liao JM; Flagg M; Cousins D; Antol DD; Shrank WH; Powers BW; Navathe AS
JAMA Health Forum; 2023 Jun; 4(6):e231495. PubMed ID: 37355996
[TBL] [Abstract][Full Text] [Related]
15. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease.
Marrufo G; Colligan EM; Negrusa B; Ullman D; Messana J; Shah A; Duvall T; Hirth RA
JAMA Intern Med; 2020 Jun; 180(6):852-860. PubMed ID: 32227133
[TBL] [Abstract][Full Text] [Related]
16. Proportion of Racial Minority Patients and Patients With Low Socioeconomic Status Cared for by Physician Groups After Joining Accountable Care Organizations.
Lee JT; Polsky D; Fitzsimmons R; Werner RM
JAMA Netw Open; 2020 May; 3(5):e204439. PubMed ID: 32383749
[TBL] [Abstract][Full Text] [Related]
17. Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer.
Moss HA; Havrilesky LJ; Wang FF; Georgieva MV; Hendrix LH; Dinan MA
J Oncol Pract; 2019 Dec; 15(12):e1018-e1027. PubMed ID: 31613721
[TBL] [Abstract][Full Text] [Related]
18. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
[TBL] [Abstract][Full Text] [Related]
19. Wide variation in payments for Medicare beneficiary oncology services suggests room for practice-level improvement.
Clough JD; Patel K; Riley GF; Rajkumar R; Conway PH; Bach PB
Health Aff (Millwood); 2015 Apr; 34(4):601-8. PubMed ID: 25847642
[TBL] [Abstract][Full Text] [Related]
20. Spending differences associated with the Medicare Physician Group Practice Demonstration.
Colla CH; Wennberg DE; Meara E; Skinner JS; Gottlieb D; Lewis VA; Snyder CM; Fisher ES
JAMA; 2012 Sep; 308(10):1015-23. PubMed ID: 22968890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
